UroGen Pharma Ltd.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2017 | $7.0M | $75.6M | $37.0M |
| Dec 2018 | $13.5M | $103.6M | $101.3M |
| Mar 2019 | $12.5M | $252.1M | $246.7M |
| Jun 2019 | $13.8M | $238.6M | $90.4M |
| Sep 2019 | $15.8M | $226.8M | $66.1M |
| Dec 2019 | $22.1M | $202.4M | $49.7M |
| Mar 2020 | $16.5M | $166.9M | $26.5M |
| Jun 2020 | $18.4M | $161.1M | $36.4M |
| Sep 2020 | $19.4M | $139.9M | $24.6M |
| Dec 2020 | $25.7M | $122.0M | $52.9M |
| Mar 2021 | $20.9M | $97.4M | $40.5M |
| Jun 2021 | $97.5M | $153.8M | $63.3M |
| Sep 2021 | $103.1M | $134.6M | $55.3M |
| Dec 2021 | $111.3M | $119.7M | $44.4M |
| Mar 2022 | $182.8M | $165.7M | $105.4M |
| Jun 2022 | $187.1M | $146.1M | $80.7M |
| Sep 2022 | $191.8M | $128.5M | $28.7M |
| Dec 2022 | $225.0M | $135.6M | $55.4M |
| Mar 2023 | $229.5M | $113.0M | $36.5M |
| Jun 2023 | $233.8M | $95.4M | $20.1M |
| Sep 2023 | $235.6M | $193.6M | $119.3M |
| Dec 2023 | $243.5M | $178.3M | $95.0M |
| Mar 2024 | $240.7M | $200.6M | $131.4M |
| Jun 2024 | $251.5M | $281.8M | $220.0M |
| Sep 2024 | $276.4M | $301.9M | $124.9M |
| Dec 2024 | $294.5M | $285.7M | $172.0M |
| Mar 2025 | $294.1M | $247.6M | $104.0M |
| Jun 2025 | $302.1M | $208.7M | $92.9M |
| Sep 2025 | $300.5M | $185.0M | $90.0M |
| Dec 2025 | $305.9M | $200.5M | $110.7M |
| Mar 2026 | $377.9M | $253.7M | $110.0M |
| Jun 2026 | $385.0M | $252.6M | $79.1M |